Promising Developments in Tackling Resistance to Blood Cancer Drugs
A new drug with the potential to reverse resistance to immunotherapy has been developed by scientists at the University of […]
Say something
Tags: antibodies, BioInvent International Aktiebolag, blood cancers, cancer, CANCER RESEARCH TECHNOLOGY LIMITED, Cancer Research UK, Cancer treatments, Chief Scientific Officer, Chris Bunce, chronic lymphocytic leukaemia, directly killing cancer, Director at Leukaemia & Lymphoma Research Research, Dr Ingrid Teige, Emma Smith, Health/Medical/Pharmaceuticals, Hodgkin's lymphoma, honorary Professor, Immune system, immunology, Immunotherapy, Ingrid Teige, leukaemia, Lymphocytic leukemia, Lymphoma, Mark Cragg, medicine, Monoclonal antibodies, Monoclonal antibody therapy, Non-Hodgkin lymphoma, non-Hodgkin lymphomas, patient's disease, professor, Professor Björn Frendéus, Professor of Experimental Cancer Research, Rituximab, Southampton, sweden, targeted tumor, therapeutics for blood cancers, treatment for several types of cancer, Tumours, University of Southampton, white blood cell cancers
ELECTRONIC MEDICAL RECORDS – A luxury or a necessity? : Prof. (Dr.) Prashant Sathe, Principal Consultant (EMR and Academics), 21st Century Health Management Solutions Pvt. Ltd.
[This article was published in the July 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
The Indian medical fraternity, especially the unorganised private sector, has been over the years quite unconcerned about preservation of patient records.
-
-
Flipkart Health+ App Launched
06-04-2022
